The COVID-19 variant that is potentially behind the recent increase in cases globally has been dubbed as 'razor blade throat' COVID. This variant, known as NB.1.8.1. or 'Nimbus,' has been associated with causing painful sore throats, as reported by doctors in the United Kingdom, India, and other countries.

Aside from sore throats, common symptoms of COVID-19 variants include fever, chills, cough, shortness of breath, and loss of taste or smell.

Experts suggest that while the Nimbus variant isn't a major concern, there are important details to be aware of.

Spread of the 'Razor Blade Throat' Variant

The recent surge in cases has been observed mainly in the eastern Mediterranean, Southeast Asia, and western Pacific regions, according to the World Health Organization. By late May, the new variant had been detected in nearly 11% of sequenced samples globally. Airport screenings in the US have identified the variant in travelers arriving from these regions to states like California, Washington, Virginia, and New York.

Likelihood of Severe Illness

As of now, there is no indication that individuals infected with the Nimbus variant are experiencing more severe symptoms compared to other variants. While some western Pacific countries have reported an increase in COVID cases and hospitalizations, the overall severity of the disease remains similar.

Effectiveness of Vaccines

The World Health Organization has classified Nimbus as a 'variant under monitoring' with a low global health risk. Current COVID-19 vaccines are anticipated to continue being effective against this variant. Despite Health Secretary Robert F. Kennedy Jr.'s recent statement that COVID-19 shots are not recommended for healthy children and pregnant women, public health experts have raised concerns about this decision.